Home › Mobidiag Completes €4M Funding Round

Mobidiag Completes €4M Funding Round

Apr 18, 2017

NEW YORK (GenomeWeb) – Finnish in vitro molecular diagnostics manufacturer Mobidiag has completed a €4.0 million ($4.3 million) funding round, the firm announced today. The funding was supported by Finnish investment service company Kansalaisrahoitus Oy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oct
02
Featured Webinar

Utilization of Multiple Molecular Testing Methodologies to Aid in Lung Cancer Patient Management

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10
Featured Webinar

Personalization of Oncology Pathways: Clinical Quality Initiatives Amid a Complex Molecular Landscape

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

What's Popular?

In Molecular Diagnostics

  1. Premaitha Licenses NIPT Tech From Illumina Under Settlement

  2. Cepheid Fingerstick HCV Test Receives CE-IVD Clearance

  3. Noridian Issues Draft LCD for GenomeDx Prostate Biopsy Genomic Classifier

  4. Qiagen, NeuMoDx Ink Partnership, Merger Agreement

  5. India's MolBio Brings Tuberculosis MDx to Point of Care With Help From FIND

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.